These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31873986)

  • 1. Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects.
    Chamani M; Maleki Dana P; Chaichian S; Moazzami B; Asemi Z
    IUBMB Life; 2020 Apr; 72(4):687-697. PubMed ID: 31873986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-based nanotherapeutics for ovarian cancer treatment.
    Alizadeh L; Zarebkohan A; Salehi R; Ajjoolabady A; Rahmati-Yamchi M
    J Drug Target; 2019 Sep; 27(8):839-852. PubMed ID: 30596291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
    Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
    Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells.
    Cocco E; Deng Y; Shapiro EM; Bortolomai I; Lopez S; Lin K; Bellone S; Cui J; Menderes G; Black JD; Schwab CL; Bonazzoli E; Yang F; Predolini F; Zammataro L; Altwerger G; de Haydu C; Clark M; Alvarenga J; Ratner E; Azodi M; Silasi DA; Schwartz PE; Litkouhi B; Saltzman WM; Santin AD
    Mol Cancer Ther; 2017 Feb; 16(2):323-333. PubMed ID: 27956521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanopolymers: An overview of drug delivery against cancer.
    Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
    Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer.
    Halbur C; Choudhury N; Chen M; Kim JH; Chung EJ
    SLAS Technol; 2019 Apr; 24(2):137-150. PubMed ID: 30616494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: a review.
    Ye H; Karim AA; Loh XJ
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():609-19. PubMed ID: 25491871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan: A compound for drug delivery system in gastric cancer-a review.
    Shafabakhsh R; Yousefi B; Asemi Z; Nikfar B; Mansournia MA; Hallajzadeh J
    Carbohydr Polym; 2020 Aug; 242():116403. PubMed ID: 32564837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review.
    Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
    Curr Med Chem; 2024; 31(23):3488-3501. PubMed ID: 37202890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment.
    Eslahi M; Dana PM; Asemi Z; Hallajzadeh J; Mansournia MA; Yousefi B
    Int J Biol Macromol; 2021 Jan; 168():124-129. PubMed ID: 33275978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
    Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
    Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
    Tian B; Hua S; Liu J
    Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics.
    Ashrafizadeh M; Ahmadi Z; Mohamadi N; Zarrabi A; Abasi S; Dehghannoudeh G; Tamaddondoust RN; Khanbabaei H; Mohammadinejad R; Thakur VK
    Int J Biol Macromol; 2020 Feb; 145():282-300. PubMed ID: 31870872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density.
    Tammam SN; Azzazy HM; Breitinger HG; Lamprecht A
    Mol Pharm; 2015 Dec; 12(12):4277-89. PubMed ID: 26465978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.
    Key J; Park K
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review.
    Wang G; Li R; Parseh B; Du G
    Carbohydr Polym; 2021 Sep; 268():118192. PubMed ID: 34127212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.